Chen Y, Jin E, Abdouh M, Bonneil E, Jimenez Cruz D, Tsering T
BMC Biol. 2025; 23(1):16.
PMID: 39838458
PMC: 11752652.
DOI: 10.1186/s12915-025-02118-w.
Dalvin L, Andrews-Pfannkoch C, Miley D, Hogenson T, Erickson S, Malpotra S
Invest Ophthalmol Vis Sci. 2024; 65(13):60.
PMID: 39601636
PMC: 11605663.
DOI: 10.1167/iovs.65.13.60.
Ferrier S, Li M, Burnier J
BMC Cancer. 2024; 24(1):1299.
PMID: 39434038
PMC: 11495039.
DOI: 10.1186/s12885-024-13037-4.
Chattopadhyay C, Roszik J, Bhattacharya R, Alauddin M, Mahmud I, Yadugiri S
Br J Cancer. 2024; 131(11):1846-1857.
PMID: 39394450
PMC: 11589887.
DOI: 10.1038/s41416-024-02866-6.
Marcotte E, Goyeneche A, Abdouh M, Burnier J, Burnier Jr M
Cancers (Basel). 2024; 16(18).
PMID: 39335202
PMC: 11429545.
DOI: 10.3390/cancers16183231.
New Insights into the Exosome-Induced Migration of Uveal Melanoma Cells and the Pre-Metastatic Niche Formation in the Liver.
Ramos R, Vinyals A, Campos-Martin R, Cabre E, Bech J, Vaquero J
Cancers (Basel). 2024; 16(17).
PMID: 39272836
PMC: 11394004.
DOI: 10.3390/cancers16172977.
The Chick Chorioallantoic Membrane as a Xenograft Model for the Quantitative Analysis of Uveal Melanoma Metastasis in Multiple Organs.
Liu H, Tsimpaki T, Anastasova R, Bechrakis N, Fiorentzis M, Berchner-Pfannschmidt U
Cells. 2024; 13(14.
PMID: 39056751
PMC: 11275209.
DOI: 10.3390/cells13141169.
Protein and mRNA Expression in Uveal Melanoma Cell Lines Are Related to GNA and BAP1 Mutation Status.
Gelmi M, de Ru A, Van Veelen P, Tjokrodirijo R, Stern M, Houy A
Invest Ophthalmol Vis Sci. 2024; 65(8):37.
PMID: 39042403
PMC: 11268447.
DOI: 10.1167/iovs.65.8.37.
Delineating three-dimensional behavior of uveal melanoma cells under anchorage independent or dependent conditions.
Goyeneche A, Lasiste J, Abdouh M, Bustamante P, Burnier J, Burnier Jr M
Cancer Cell Int. 2024; 24(1):180.
PMID: 38783299
PMC: 11118898.
DOI: 10.1186/s12935-024-03350-0.
Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting.
Ventin M, Cattaneo G, Arya S, Jia J, Gelmi M, Sun Y
Clin Cancer Res. 2024; 30(15):3243-3258.
PMID: 38767611
PMC: 11572477.
DOI: 10.1158/1078-0432.CCR-24-0071.
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy.
Lischer C, Eberhardt M, Flamann C, Berges J, Guse E, Wessely A
J Immunother Cancer. 2024; 12(5).
PMID: 38724462
PMC: 11086525.
DOI: 10.1136/jitc-2023-008104.
Quercetin Impairs the Growth of Uveal Melanoma Cells by Interfering with Glucose Uptake and Metabolism.
Tura A, Herfs V, Maassen T, Zuo H, Vardanyan S, Prasuhn M
Int J Mol Sci. 2024; 25(8).
PMID: 38673877
PMC: 11049862.
DOI: 10.3390/ijms25084292.
Uveal melanoma cell lines Mel270 and 92.1 exhibit a mesenchymal phenotype and sensitivity to the cytostatic effects of transforming growth factor beta in vitro.
Doudnikoff C, Leclerc D, Angenard G, Gilot D, Coulouarn C, Mouriaux F
Mol Vis. 2024; 30:160-166.
PMID: 38601020
PMC: 11006005.
A centrosome-related gene signature for predicting the overall survival of uveal melanoma.
Yu X, Guo X, Li W, Li J
Transl Cancer Res. 2024; 13(2):771-781.
PMID: 38482432
PMC: 10928595.
DOI: 10.21037/tcr-23-1486.
Impact of Nintedanib and Anti-Angiogenic Agents on Uveal Melanoma Cell Behavior.
Pawlik V, Sonntag S, Grisanti S, Tura A, Kakkassery V, Ranjbar M
Invest Ophthalmol Vis Sci. 2024; 65(2):30.
PMID: 38381412
PMC: 10893901.
DOI: 10.1167/iovs.65.2.30.
1,4-dihydroxy quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature.
Tonelotto V, Costa-Garcia M, OReilly E, Smith K, Slater K, Dillon E
Cell Death Discov. 2024; 10(1):70.
PMID: 38341410
PMC: 10858877.
DOI: 10.1038/s41420-023-01773-8.
CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells.
Togashi K, Suzuki S, Mitobe Y, Nakagawa-Saito Y, Sugai A, Takenouchi S
Cancers (Basel). 2024; 16(1).
PMID: 38201546
PMC: 10778035.
DOI: 10.3390/cancers16010118.
Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes.
Sundaramurthi H, Tonelotto V, Wynne K, OConnell F, OReilly E, Costa-Garcia M
Open Res Eur. 2023; 3:88.
PMID: 37981907
PMC: 10654492.
DOI: 10.12688/openreseurope.15973.2.
The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma.
Boudreau M, Tonogai E, Schane C, Xi M, Fischer J, Vijayakumar J
Melanoma Res. 2023; 33(6):514-524.
PMID: 37738028
PMC: 10615773.
DOI: 10.1097/CMR.0000000000000927.
Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma.
Gentien D, Saberi-Ansari E, Servant N, Jolly A, De La Grange P, Nemati F
Cell Rep. 2023; 42(9):113132.
PMID: 37708024
PMC: 10598242.
DOI: 10.1016/j.celrep.2023.113132.